COVID-19: Vaccines and Therapeutics
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., today encouraged all eligible Americans to get vaccinated against the flu and COVID-19, noting that hospitals continue to experience the highest flu admissions in a decade this early in the season.
The Food and Drug Administration does not currently authorize the monoclonal antibody bamlanivimab for emergency use to treat mild-to-moderate COVID-19 in the United States because it is not expected to neutralize the predominating BQ.1 and BQ.1.1. omicron subvariants.
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection compared with previous vaccination with two or more monovalent doses, the Centers for Disease Control and Prevention reported today. The…
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine.
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according to a study released today by the Centers for Disease Control and Prevention.
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics.
When COVID-19 vaccines were first authorized for children, infectious disease specialists at Akron Children’s Hospital shared evidence-based information and answered parents’ and caregivers’ questions. The hospital team continues to discuss the latest updates on COVID-19 and allergies, asthma and…
Clinicians at St. Louis Children’s Hospital are making sure parents and caregivers know how to evaluate respiratory illness symptoms when children get sick during the peak of cold and flu season when RSV and COVID-19 cases are expected to rise. The hospital continues to urge COVID-19 vaccination…
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected to neutralize omicron subvariants BQ.1 and BQ.1.1.
Black patients who sought outpatient care for COVID-19 between January and July 2022 were 36% less likely than white patients to receive the antiviral pill Paxlovid, while Hispanic patients were 30% less likely than non-Hispanic patients to receive the treatment, according to a study released today…